Thalys Medical Technology Group Corporation(603716) : the subsidiary signed the sales contract of covid-19 test kit of USD 20 million

Thalys Medical Technology Group Corporation(603716) on January 20, it was announced that Thales biotechnology, a wholly-owned subsidiary of the company, signed the sales partner agreement with ate gold kuyumculuk on January 20, 2022. Ate gold kuyumculuk purchased $20 million from biotechnology in the first phase. The covid-19 test kit independently developed and produced by ate gold kuyumculuk has the first trial order amount of $1 million. At present, the other party has paid a deposit of $100000. The contract is completed by stages, and the specific delivery time has not been determined. There may be a risk of long sales time or inability to sell.